Pharmacist's Influence on Breast Cancer Patient Quality of Life

University Hospital Sestre Milosrdnice70 enrolled

Overview

The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Breast Cancer, Quality of Life

Interventions

Pharmacist's behavioral interventionBEHAVIORAL

Pharmacist's 30 min counselling on antiemetic therapy, causes of nausea or vomiting and ways to prevent them during chemotherapy.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Early breast cancer * First adjuvant chemotherapy * Chemotherapy protocol: anthracycline x 4 Exclusion Criteria: * Cardiovascular comorbidities * Regular nausea or vomiting during six months before enrollment * Unable to answer the quality of life questionnaire on their own

Outcomes

Primary Outcomes

changes in quality of life of a breast cancer patient under chemotherapy, after a clinical pharmacist's behavioral intervention, measured by EORTC B23 questionnaire

Time frame: up to two months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.